Suven Pharmaceuticals

1,055.80
+0.75
(0.07%)
Market Cap
26,876.97
EPS
9.45
PE Ratio (TTM)
110.45
Dividend Yield
0.00
Industry
Healthcare
52 Week High
1,360.00
52 Week low
585.20
PB Ratio
13.57
Debt to Equity
0.04
Sector
Pharmaceuticals
Add Ratio

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Growth Rate
Revenue Growth
-19.72 %
Net Income Growth
-26.99 %
Cash Flow Change
-21.59 %
ROE
-38.23 %
ROCE
-39.27 %
EBITDA Margin (Avg.)
-6.12 %

Yearly Financial Results

Annual Financials
2019
2020
2021
2022
2023
2024
TTM
Revenue
378
852
1,024
1,413
1,387
1,113
1,025
Expenses
206
452
569
741
766
646
638
EBITDA
172
400
455
672
621
468
387
Operating Profit %
45 %
46 %
44 %
44 %
43 %
39 %
34 %
Depreciation
12
24
32
39
48
55
61
Interest
3
20
9
6
13
8
8
Profit Before Tax
158
405
468
668
560
406
319
Tax
49
88
105
214
148
105
76
Net Profit
109
317
362
454
411
300
243
EPS in ₹
8.59
12.45
14.23
17.83
16.60
11.80
9.60

Balance Sheet

Balance Sheet
2019
2020
2021
2022
2023
2024
Total Assets
783
1,173
1,475
1,830
1,966
2,254
Fixed Assets
271
357
441
534
663
670
Current Assets
390
392
565
1,128
1,011
1,263
Capital Work in Progress
111
102
96
30
165
179
Investments
7
338
542
598
536
905
Other Assets
394
376
395
667
601
501
Total Liabilities
783
1,173
1,475
1,830
1,966
2,254
Current Liabilities
158
200
220
210
159
107
Non Current Liabilities
35
128
74
92
72
97
Total Equity
590
845
1,181
1,527
1,735
2,051
Reserve & Surplus
578
832
1,155
1,502
1,710
2,025
Share Capital
13
13
26
26
26
26

Cash Flow

Cash Flow
2019
2020
2021
2022
2023
2024
Net Cash Flow
11
1
-5
37
20
-18
Investing Activities
-66
-414
-311
-136
-195
-362
Operating Activities
50
407
383
330
457
359
Financing Activities
26
7
-76
-157
-242
-14

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Promoter
60.00 %
60.00 %
60.00 %
60.00 %
60.00 %
60.00 %
60.00 %
60.00 %
60.00 %
60.00 %
60.00 %
60.00 %
50.10 %
50.10 %
50.10 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
10.01 %
10.14 %
9.54 %
9.80 %
10.70 %
DIIs
4.30 %
4.47 %
4.94 %
5.24 %
5.91 %
6.32 %
10.52 %
11.35 %
11.43 %
9.23 %
14.14 %
15.94 %
17.24 %
17.42 %
16.94 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
Public / Retail
20.87 %
19.86 %
19.21 %
18.38 %
17.07 %
16.86 %
14.69 %
14.01 %
12.76 %
12.80 %
11.76 %
10.87 %
10.51 %
10.08 %
9.75 %
No of Share Holders
75,207
92,534
96,532
86,447
85,725
86,088
82,577
79,412
72,885
72,167
73,715
70,052
68,932
65,777
69,337

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 5 2 5 6 0.00 0.00
Dividend Yield (%) 0.00 0.00 0.00 0.00 1.01 0.32 1.06 0.89 0.00 0.00
Competitors LTP Market Cap (₹ Cr.) P/E Ratio Revenue (₹ Cr.) YoY Revenue Growth % Net Profit (₹ Cr.) YoY Profit Growth % RSI
1,756.85 4,21,527.16 37.86 49,887.20 12.06 9,648 27.34 36.22
5,876.85 1,56,011.90 86.72 8,184.00 0.89 1,600 46.55 47.97
1,447.20 1,16,877.90 25.33 26,520.70 14.17 4,155 12.95 38.47
1,337.20 1,11,577.42 20.90 28,905.40 12.36 5,578 -9.47 52.63
3,215.05 1,08,811.90 63.29 10,785.70 11.59 1,656 17.36 36.47
2,596.00 1,07,102.37 52.12 10,615.60 19.57 1,942 28.89 38.60
984.90 99,103.99 23.54 19,831.50 13.82 3,831 14.57 50.66
2,128.70 97,110.78 37.44 20,141.50 19.94 1,936 73.53 39.84
1,147.55 66,649.89 18.88 29,559.20 17.55 3,169 8.66 30.14
5,201.50 62,191.73 28.99 12,978.40 9.84 1,812 14.16 33.33

Corporate Action

Technical Indicators

RSI(14)
Neutral
25.39
ATR(14)
Less Volatile
43.30
STOCH(9,6)
Neutral
20.14
STOCH RSI(14)
Oversold
15.62
MACD(12,26)
Bearish
-3.87
ADX(14)
Strong Trend
40.68
UO(9)
Bearish
39.15
ROC(12)
Downtrend But Slowing Down
-7.67
WillR(14)
Oversold
-90.58